Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentaglobin Effects on Microcirculation in Sepsis
NCT02655133Phase 2Completed
- Sponsor
- Università Politecnica delle Marche
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of Pentaglobin in sepsis, septic shock, sponsored by Università Politecnica delle Marche. Started Jan 2016; status: completed.
02
Drugs
Pentaglobin
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT02655133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655133.